GO:0043228 | non-membrane-bounded organelle | 33.33% (20/60) | 1.92 | 0.0 | 6.2e-05 |
GO:0043232 | intracellular non-membrane-bounded organelle | 33.33% (20/60) | 1.92 | 0.0 | 6.2e-05 |
GO:0006807 | nitrogen compound metabolic process | 60.0% (36/60) | 1.1 | 0.0 | 6.3e-05 |
GO:0044238 | primary metabolic process | 65.0% (39/60) | 1.03 | 0.0 | 6.3e-05 |
GO:0006139 | nucleobase-containing compound metabolic process | 35.0% (21/60) | 1.79 | 0.0 | 6.7e-05 |
GO:0003824 | catalytic activity | 65.0% (39/60) | 0.98 | 0.0 | 8.9e-05 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 18.33% (11/60) | 2.82 | 0.0 | 9.4e-05 |
GO:0005575 | cellular_component | 90.0% (54/60) | 0.56 | 1e-06 | 9.8e-05 |
GO:0008152 | metabolic process | 71.67% (43/60) | 0.85 | 1e-06 | 0.000107 |
GO:0090304 | nucleic acid metabolic process | 30.0% (18/60) | 1.86 | 1e-06 | 0.000113 |
GO:1901360 | organic cyclic compound metabolic process | 43.33% (26/60) | 1.39 | 1e-06 | 0.000116 |
GO:0008150 | biological_process | 90.0% (54/60) | 0.55 | 1e-06 | 0.000119 |
GO:0006259 | DNA metabolic process | 18.33% (11/60) | 2.72 | 1e-06 | 0.000123 |
GO:0046483 | heterocycle metabolic process | 38.33% (23/60) | 1.54 | 1e-06 | 0.000124 |
GO:0140097 | catalytic activity, acting on DNA | 11.67% (7/60) | 3.67 | 1e-06 | 0.000147 |
GO:0034641 | cellular nitrogen compound metabolic process | 41.67% (25/60) | 1.61 | 0.0 | 0.000159 |
GO:0044237 | cellular metabolic process | 63.33% (38/60) | 0.9 | 3e-06 | 0.000286 |
GO:0043570 | maintenance of DNA repeat elements | 5.0% (3/60) | 6.76 | 3e-06 | 0.000294 |
GO:0071704 | organic substance metabolic process | 66.67% (40/60) | 0.85 | 3e-06 | 0.000301 |
GO:0003674 | molecular_function | 86.67% (52/60) | 0.54 | 5e-06 | 0.00047 |
GO:0009987 | cellular process | 80.0% (48/60) | 0.62 | 8e-06 | 0.000648 |
GO:0006725 | cellular aromatic compound metabolic process | 38.33% (23/60) | 1.35 | 9e-06 | 0.000778 |
GO:0140513 | nuclear protein-containing complex | 18.33% (11/60) | 2.27 | 1.4e-05 | 0.001129 |
GO:0043170 | macromolecule metabolic process | 46.67% (28/60) | 1.06 | 2.8e-05 | 0.002075 |
GO:0048513 | animal organ development | 15.0% (9/60) | 2.41 | 4.6e-05 | 0.003318 |
GO:0006310 | DNA recombination | 8.33% (5/60) | 3.66 | 4.8e-05 | 0.003343 |
GO:0044818 | mitotic G2/M transition checkpoint | 5.0% (3/60) | 5.35 | 5.7e-05 | 0.003793 |
GO:0006281 | DNA repair | 11.67% (7/60) | 2.8 | 6.5e-05 | 0.004192 |
GO:0006974 | cellular response to DNA damage stimulus | 13.33% (8/60) | 2.49 | 8.3e-05 | 0.005208 |
GO:0048856 | anatomical structure development | 41.67% (25/60) | 1.06 | 9.9e-05 | 0.005794 |
GO:0110165 | cellular anatomical entity | 83.33% (50/60) | 0.47 | 9.7e-05 | 0.005873 |
GO:0016073 | snRNA metabolic process | 5.0% (3/60) | 5.05 | 0.000105 | 0.005944 |
GO:1903047 | mitotic cell cycle process | 11.67% (7/60) | 2.65 | 0.000125 | 0.006848 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 5.0% (3/60) | 4.87 | 0.000154 | 0.007938 |
GO:1902750 | negative regulation of cell cycle G2/M phase transition | 5.0% (3/60) | 4.87 | 0.000154 | 0.007938 |
GO:0044260 | cellular macromolecule metabolic process | 25.0% (15/60) | 1.51 | 0.000159 | 0.008002 |
GO:0099081 | supramolecular polymer | 10.0% (6/60) | 2.81 | 0.000211 | 0.009766 |
GO:0099512 | supramolecular fiber | 10.0% (6/60) | 2.81 | 0.000211 | 0.009766 |
GO:0015074 | DNA integration | 3.33% (2/60) | 6.44 | 0.00024 | 0.009875 |
GO:0005488 | binding | 73.33% (44/60) | 0.55 | 0.000202 | 0.009897 |
GO:0000166 | nucleotide binding | 26.67% (16/60) | 1.39 | 0.000237 | 0.009968 |
GO:1901265 | nucleoside phosphate binding | 26.67% (16/60) | 1.39 | 0.000237 | 0.009968 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 11.67% (7/60) | 2.51 | 0.000221 | 0.009977 |
GO:0032991 | protein-containing complex | 30.0% (18/60) | 1.28 | 0.000233 | 0.010292 |
GO:0016787 | hydrolase activity | 26.67% (16/60) | 1.38 | 0.000263 | 0.010563 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 5.0% (3/60) | 4.52 | 0.000311 | 0.011951 |
GO:0000439 | transcription factor TFIIH core complex | 3.33% (2/60) | 6.26 | 0.00031 | 0.01221 |
GO:0008094 | ATP-dependent activity, acting on DNA | 6.67% (4/60) | 3.55 | 0.000391 | 0.014453 |
GO:0004652 | polynucleotide adenylyltransferase activity | 3.33% (2/60) | 6.1 | 0.00039 | 0.014683 |
GO:0022402 | cell cycle process | 15.0% (9/60) | 1.97 | 0.000438 | 0.015834 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6.67% (4/60) | 3.46 | 0.000485 | 0.016857 |
GO:1901363 | heterocyclic compound binding | 45.0% (27/60) | 0.86 | 0.000494 | 0.016868 |
GO:0034472 | snRNA 3'-end processing | 3.33% (2/60) | 5.96 | 0.000478 | 0.016938 |
GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.33% (2/60) | 5.89 | 0.000525 | 0.017579 |
GO:0097159 | organic cyclic compound binding | 45.0% (27/60) | 0.85 | 0.000555 | 0.017939 |
GO:0043229 | intracellular organelle | 61.67% (37/60) | 0.63 | 0.000546 | 0.017951 |
GO:0005874 | microtubule | 8.33% (5/60) | 2.88 | 0.000592 | 0.018468 |
GO:1902494 | catalytic complex | 16.67% (10/60) | 1.78 | 0.000589 | 0.018684 |
GO:0043226 | organelle | 61.67% (37/60) | 0.62 | 0.000621 | 0.019035 |
GO:0036094 | small molecule binding | 26.67% (16/60) | 1.25 | 0.000722 | 0.021407 |
GO:0140098 | catalytic activity, acting on RNA | 10.0% (6/60) | 2.48 | 0.000711 | 0.021445 |
GO:0000729 | DNA double-strand break processing | 3.33% (2/60) | 5.59 | 0.000793 | 0.02315 |
GO:0031570 | DNA integrity checkpoint signaling | 5.0% (3/60) | 4.01 | 0.000871 | 0.024997 |
GO:0099080 | supramolecular complex | 11.67% (7/60) | 2.15 | 0.000974 | 0.027517 |
GO:0005741 | mitochondrial outer membrane | 5.0% (3/60) | 3.93 | 0.001024 | 0.02807 |
GO:0031123 | RNA 3'-end processing | 5.0% (3/60) | 3.93 | 0.001024 | 0.02807 |
GO:0043138 | 3'-5' DNA helicase activity | 3.33% (2/60) | 5.39 | 0.001047 | 0.028268 |
GO:0005730 | nucleolus | 13.33% (8/60) | 1.94 | 0.00108 | 0.028316 |
GO:0051276 | chromosome organization | 8.33% (5/60) | 2.69 | 0.001065 | 0.028327 |
GO:0060716 | labyrinthine layer blood vessel development | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0006548 | histidine catabolic process | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0030735 | carnosine N-methyltransferase activity | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0035498 | carnosine metabolic process | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0016076 | snRNA catabolic process | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0071036 | nuclear polyadenylation-dependent snoRNA catabolic process | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0071037 | nuclear polyadenylation-dependent snRNA catabolic process | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0071039 | nuclear polyadenylation-dependent CUT catabolic process | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0071040 | nuclear polyadenylation-dependent antisense transcript catabolic process | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0071041 | antisense RNA transcript catabolic process | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0009551 | secondary plasmodesma | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0097218 | sieve plate | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0019912 | cyclin-dependent protein kinase activating kinase activity | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0042795 | snRNA transcription by RNA polymerase II | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0071619 | phosphorylation of RNA polymerase II C-terminal domain serine 2 residues | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0071620 | phosphorylation of RNA polymerase II C-terminal domain serine 5 residues | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0034477 | U6 snRNA 3'-end processing | 1.67% (1/60) | 9.35 | 0.001535 | 0.028925 |
GO:0016229 | steroid dehydrogenase activity | 3.33% (2/60) | 5.3 | 0.001186 | 0.030662 |
GO:0016180 | snRNA processing | 3.33% (2/60) | 5.06 | 0.001655 | 0.03087 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 5.0% (3/60) | 3.82 | 0.001272 | 0.031952 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 3.33% (2/60) | 5.26 | 0.001259 | 0.032088 |
GO:0017076 | purine nucleotide binding | 18.33% (11/60) | 1.52 | 0.001318 | 0.03222 |
GO:0050794 | regulation of cellular process | 48.33% (29/60) | 0.73 | 0.001342 | 0.032364 |
GO:0099513 | polymeric cytoskeletal fiber | 8.33% (5/60) | 2.63 | 0.001308 | 0.032409 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 5.0% (3/60) | 3.77 | 0.001408 | 0.033524 |
GO:0016874 | ligase activity | 6.67% (4/60) | 3.04 | 0.001448 | 0.033582 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 5.0% (3/60) | 3.76 | 0.001437 | 0.033756 |
GO:0000725 | recombinational repair | 5.0% (3/60) | 3.74 | 0.001495 | 0.034227 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 6.67% (4/60) | 2.94 | 0.001869 | 0.034503 |
GO:0031966 | mitochondrial membrane | 6.67% (4/60) | 2.93 | 0.001909 | 0.03489 |
GO:0140657 | ATP-dependent activity | 10.0% (6/60) | 2.19 | 0.00201 | 0.036354 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 6.67% (4/60) | 2.9 | 0.002076 | 0.036824 |
GO:0032502 | developmental process | 45.0% (27/60) | 0.74 | 0.002071 | 0.037087 |
GO:0004540 | ribonuclease activity | 5.0% (3/60) | 3.57 | 0.002119 | 0.037208 |
GO:0051128 | regulation of cellular component organization | 16.67% (10/60) | 1.52 | 0.00223 | 0.038791 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 3.33% (2/60) | 4.82 | 0.002296 | 0.039559 |
GO:0097367 | carbohydrate derivative binding | 18.33% (11/60) | 1.41 | 0.00243 | 0.041463 |
GO:0035639 | purine ribonucleoside triphosphate binding | 16.67% (10/60) | 1.5 | 0.002462 | 0.041628 |
GO:0010216 | maintenance of DNA methylation | 3.33% (2/60) | 4.76 | 0.002498 | 0.041834 |
GO:0006298 | mismatch repair | 3.33% (2/60) | 4.73 | 0.002601 | 0.043171 |
GO:0000075 | cell cycle checkpoint signaling | 5.0% (3/60) | 3.45 | 0.002668 | 0.04348 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 5.0% (3/60) | 3.45 | 0.002668 | 0.04348 |
GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters | 3.33% (2/60) | 4.7 | 0.002707 | 0.043722 |
GO:0016070 | RNA metabolic process | 16.67% (10/60) | 1.48 | 0.002739 | 0.043849 |
GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity | 1.67% (1/60) | 8.35 | 0.003068 | 0.045863 |
GO:0102175 | 3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity | 1.67% (1/60) | 8.35 | 0.003068 | 0.045863 |
GO:0102191 | 4alpha-carboxy-5alpha-cholesta-7,24-dien-3beta-ol dehydrogenase/C4-decarboxylase activity | 1.67% (1/60) | 8.35 | 0.003068 | 0.045863 |
GO:0004573 | Glc3Man9GlcNAc2 oligosaccharide glucosidase activity | 1.67% (1/60) | 8.35 | 0.003068 | 0.045863 |
GO:0015220 | choline transmembrane transporter activity | 1.67% (1/60) | 8.35 | 0.003068 | 0.045863 |
GO:0065007 | biological regulation | 55.0% (33/60) | 0.58 | 0.002912 | 0.046205 |
GO:0032501 | multicellular organismal process | 33.33% (20/60) | 0.89 | 0.003161 | 0.046867 |
GO:0033043 | regulation of organelle organization | 10.0% (6/60) | 2.07 | 0.002982 | 0.04691 |
GO:1903046 | meiotic cell cycle process | 8.33% (5/60) | 2.34 | 0.003054 | 0.047633 |
GO:0006643 | membrane lipid metabolic process | 5.0% (3/60) | 3.34 | 0.003298 | 0.048503 |
GO:0070566 | adenylyltransferase activity | 3.33% (2/60) | 4.54 | 0.003383 | 0.048959 |
GO:0061647 | histone H3-K9 modification | 3.33% (2/60) | 4.54 | 0.003383 | 0.048959 |